Results 31 to 40 of about 93,845 (280)

Exploring the baseline knowledge and experience of healthcare professionals in the United Kingdom on Novel Psychoactive Substances [PDF]

open access: yes, 2020
Submitted 28 january 2020. Reviwers' comments received 11 February 2020. Accepted 26 February 2020. Published 2 March 2020.Objective: This survey aimed to explore knowledge and experience on novel psychoactive substances (NPS) of healthcare professionals
Bancroft, Angus   +9 more
core   +3 more sources

Rational Drug Design Paradigms: The Odyssey for Designing Better Drugs

open access: yesCombinatorial Chemistry & High Throughput Screening, 2015
Due to the time and effort requirements for the development of a new drug, and the high attrition rates associated with this developmental process, there is an intense effort by academic and industrial researchers to find novel ways for more effective drug development schemes.
Kellici T   +13 more
openaire   +4 more sources

2-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUG

open access: yesQuímica Nova, 2016
Drug trafficking and the introduction of new drugs onto the illicit market are one of the main challenges of the forensic community. In this study, the chemical profile of a new designer drug, 2-(4-iodine-2,5-dimethoxyphenyl)-n-[(2-methoxyphenyl)methyl ...
Pâmella F. dos Santos   +11 more
doaj   +1 more source

Hazard Characterization of Synthetic Cathinones Using Viability, Monoamine Reuptake, and Neuronal Activity Assays

open access: yesFrontiers in Neuroscience, 2020
Synthetic cathinones are the second largest class of new psychoactive substances (NPS) on the drug market. Despite the large number of different cathinones and their abundant use, hazard characterization is mainly limited to their potential to inhibit ...
Anne Zwartsen   +4 more
doaj   +1 more source

Activation of Ventral Tegmental Area 5-HT2C Receptors Reduces Incentive Motivation [PDF]

open access: yes, 2016
FUNDING AND DISCLOSURE The research was funded by Wellcome Trust (WT098012) to LKH; and National Institute of Health (DK056731) and the Marilyn H. Vincent Foundation to MGM.
AH Rezvani   +55 more
core   +1 more source

Roar of meow-meow (mephedrone) in India

open access: yesJournal of Mental Health and Human Behaviour, 2015
Recently, a dangerous new designer drug mephedrone has fast gained popularity among the youth and teens of India. Its abuse has soared to mount to an epidemic.
Pooja Yudhishthir Palkar   +1 more
doaj   +1 more source

Clinical pattern of poisoning among patients declared as taking novel recreational drugs

open access: yesInternational Journal of Occupational Medicine and Environmental Health, 2020
Objectives Intoxication with novel psychoactive drugs poses a significant challenge for medicine due to diagnostic difficulties, complex clinical patterns resulting from the polyethiology of poisoning, and the risk of fatal complications.
Anna Krakowiak   +3 more
doaj   +1 more source

Multianalyte LC-MS-based methods in doping control: what are the implications for doping athletes? [PDF]

open access: yes, 2016
Over the last 50 years, the list of doping substances and methods has been progressively expanding, being regularly reviewed by the international antidoping authorities (formerly the Medical Commission of the International Olympic Committee, and ...
Botre', Francesco   +2 more
core   +1 more source

Piperazine derivatives as dangerous abused compounds

open access: yesActa Pharmaceutica, 2020
Piperazine derivatives are a group of compounds with a psychostimulant effect. They are an alternative to illegal drugs. They are being searched for recreational use due to their psychoactive and hallucinogenic effects.
Welz Anna, Koba Marcin
doaj   +1 more source

Recent trends in analytical methods to determine new psychoactive substances in hair [PDF]

open access: yes, 2017
New Psychoactive Substances (NPS) belong to several chemical classes, including phenethylamines, piperazines, synthetic cathinones and synthetic cannabinoids.
García Algar, Oscar   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy